Tumor Necrosis Factor Receptor Blocking Activity [MoA] - N0000175451

Pharmacologic Class Information

Pharmacologic Code N0000175451
Pharmacologic Name Tumor Necrosis Factor Receptor Blocking Activity
Pharmacologic Uses
  • tumor necrosis factor (TNF) blocker
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Tumor Necrosis Factor Receptor Blocking Activity

The following table contains 23 products whose active ingredient are classified under the same pharmacologic class Tumor Necrosis Factor Receptor Blocking Activity [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-4305Renflexis Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousMerck Sharp & Dohme Corp.ACTIVE
0069-0809Inflectra Non-Proprietary Name: Infliximab-dyybInjection, Powder, Lyophilized, For SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50090-3531Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-4490Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-4590Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousA-s Medication SolutionsACTIVE
50474-710Cimzia Non-Proprietary Name: Certolizumab PegolInjection, SolutionSubcutaneousUcb, Inc.ACTIVE
55513-670Avsola Non-Proprietary Name: Infliximab-axxqInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncACTIVE
57894-030Remicade Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-070Simponi Non-Proprietary Name: GolimumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-071Simponi Non-Proprietary Name: GolimumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-160Infliximab Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-350Simponi Aria Non-Proprietary Name: GolimumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
58406-010Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-021Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-032Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-044Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-055Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-435Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-445Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-446Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-455Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
58406-456Enbrel Non-Proprietary Name: EtanerceptSolutionSubcutaneousImmunex CorporationACTIVE
78206-162Renflexis Non-Proprietary Name: InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousOrganon LlcACTIVE